{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T01:21:53Z","timestamp":1790385713578,"version":"4.1.0"},"reference-count":32,"publisher":"Wiley","issue":"8","license":[{"start":{"date-parts":[[2021,4,9]],"date-time":"2021-04-09T00:00:00Z","timestamp":1617926400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["P01AG027296"],"award-info":[{"award-number":["P01AG027296"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R03AG060073"],"award-info":[{"award-number":["R03AG060073"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["agsjournals.onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["J American Geriatrics Society"],"published-print":{"date-parts":[[2021,8]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Importance<\/jats:title>\n                    <jats:p>The Centers for Medicare &amp; Medicaid Services' (CMS) National Partnership to Improve Dementia Care in Nursing Homes (\u201cCMS National Partnership\u201d) focuses on reducing antipsychotic prescribing to long\u2010term care residents. Hospice enrollment is not an exclusionary condition for the antipsychotic quality measure reported by CMS. It is unclear how prescribing in hospice may have been impacted by the initiative.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>Estimate the association of the CMS National Partnership with trends in antipsychotic prescribing among long\u2010term care residents in hospice.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Design<\/jats:title>\n                    <jats:p>Interrupted time\u2010series analysis of a 100% Minimum Data Set sample with linked hospice claims from 2011 to 2017.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Setting<\/jats:title>\n                    <jats:p>Long\u2010term care nursing facilities.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Participants<\/jats:title>\n                    <jats:p>\n                      Older adults \u226565 residing in long\u2010term care (\n                      <jats:italic>n<\/jats:italic>\n                      \u00a0=\u00a03,741,379) and limited to those enrolled in hospice (\n                      <jats:italic>n<\/jats:italic>\n                      \u00a0=\u00a0821,610).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Main outcome<\/jats:title>\n                    <jats:p>Quarterly prevalence of antipsychotic and other psychotropic (antianxiety, hypnotic, antidepressant) use among long\u2010term care residents; overall and among residents with dementia, stratified by hospice enrollment.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>From 2011 to 2017, parallel declines in antipsychotic prescribing were observed among long\u2010term care residents enrolled and not enrolled in hospice (hospice: decline from 26.8% to 18.7%; non\u2010hospice: decline from 23.0% to 14.4%). Following the 2012 CMS National Partnership, quarterly rates of antipsychotic prescribing declined significantly for both residents enrolled and not enrolled in hospice care. Declines in antipsychotic prescribing were greater for residents with dementia, with similar rates among residents enrolled and not enrolled in hospice. Among residents with dementia enrolled in hospice, use of other psychotropic medication classes including antianxiety, antidepressant, and hypnotic use remained relatively stable over time.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions and relevance<\/jats:title>\n                    <jats:p>Declines in antipsychotic prescribing during the CMS National Partnership occurred among long\u2010term care residents in hospice, where use may be deemed clinically appropriate. Nursing homes are an important location for the provision of dementia end\u2010of\u2010life care and the drivers of potentially unintended reductions in antipsychotic use merits further investigation.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1111\/jgs.17172","type":"journal-article","created":{"date-parts":[[2021,4,10]],"date-time":"2021-04-10T00:21:02Z","timestamp":1618014062000},"page":"2152-2162","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":14,"title":["Trends in antipsychotic prescribing among long\u2010term care residents receiving hospice care"],"prefix":"10.1111","volume":"69","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1943-0150","authenticated-orcid":false,"given":"Lauren B.","family":"Gerlach","sequence":"first","affiliation":[{"name":"Department of Psychiatry University of Michigan  Ann Arbor Michigan USA"},{"name":"Institute for Healthcare Policy and Innovation University of Michigan  Ann Arbor Michigan USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0077-5047","authenticated-orcid":false,"given":"Shekinah","family":"Fashaw","sequence":"additional","affiliation":[{"name":"Center for Gerontology and Healthcare Research Brown University  Providence Rhode Island USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julie","family":"Strominger","sequence":"additional","affiliation":[{"name":"Center for Clinical Management Research VA Ann Arbor Healthcare System  Ann Arbor Michigan USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jessica","family":"Ogarek","sequence":"additional","affiliation":[{"name":"Center for Gerontology and Healthcare Research Brown University  Providence Rhode Island USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1673-4570","authenticated-orcid":false,"given":"Andrew R.","family":"Zullo","sequence":"additional","affiliation":[{"name":"Center for Gerontology and Healthcare Research Brown University  Providence Rhode Island USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lori A.","family":"Daiello","sequence":"additional","affiliation":[{"name":"Center for Gerontology and Healthcare Research Brown University  Providence Rhode Island USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joan","family":"Teno","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine Oregon Health and Sciences University  Portland Oregon USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Theresa I.","family":"Shireman","sequence":"additional","affiliation":[{"name":"Center for Gerontology and Healthcare Research Brown University  Providence Rhode Island USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julie P. W.","family":"Bynum","sequence":"additional","affiliation":[{"name":"Institute for Healthcare Policy and Innovation University of Michigan  Ann Arbor Michigan USA"},{"name":"Department of Internal Medicine University of Michigan  Ann Arbor Michigan USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2021,4,9]]},"reference":[{"key":"e_1_2_11_2_1","unstructured":"Office of Inspector General U.S. Department of Health and Human Services.Medicare atypical antipsychotic drug claims for elderly nursing home residents; 2011.https:\/\/oig.hhs.gov\/oei\/reports\/oei\u201007e08e00150.pdf. Accessed August 29 2020."},{"key":"e_1_2_11_3_1","unstructured":"Centers for Medicare and Medicaid Services.CMS announces partnership to improve dementia care in nursing homes;2012.https:\/\/www.cms.gov\/newsroom\/press\u2010releases\/cms\u2010announces\u2010partnership\u2010improve\u2010dementia\u2010care\u2010nursing\u2010homes. Accessed March 23 2020."},{"key":"e_1_2_11_4_1","unstructured":"Medicare.gov.About nursing home compare data.https:\/\/www.medicare.gov\/nursinghomecompare\/Data\/About.html. Accessed October 21 2020."},{"key":"e_1_2_11_5_1","doi-asserted-by":"publisher","DOI":"10.1001\/archinte.164.3.321"},{"key":"e_1_2_11_6_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1532-5415.2005.53118.x"},{"key":"e_1_2_11_7_1","doi-asserted-by":"publisher","DOI":"10.1177\/1049909113476132"},{"key":"e_1_2_11_8_1","doi-asserted-by":"publisher","DOI":"10.1111\/jgs.15767"},{"key":"e_1_2_11_9_1","unstructured":"Centers for Medicare & Mediaid Services.MDS 3.0 Quality Measures User's Manual October 2020.https:\/\/www.cms.gov\/Medicare\/Quality\u2010Initiatives\u2010Patient\u2010Assessment\u2010Instruments\/NursingHomeQualityInits\/NHQIQualityMeasures. Accessed August 1 2020."},{"key":"e_1_2_11_10_1","doi-asserted-by":"publisher","DOI":"10.1111\/jgs.14196"},{"key":"e_1_2_11_11_1","unstructured":"Centers for Medicare & Medicaid Services.Data show National Partnership to Improve Dementia Care achieves goals to reduce unnecessary antipsychotic medications in nursing homes; 2017.https:\/\/www.cms.gov\/newsroom\/fact\u2010sheets\/data\u2010show\u2010national\u2010partnership\u2010improve\u2010dementia\u2010care\u2010achieves\u2010goals\u2010reduce\u2010unnecessary\u2010antipsychotic. Accessed on October 1 2020."},{"key":"e_1_2_11_12_1","unstructured":"Centers for Medicare & Medicaid Services.National partnership to improve dementia care in nursing homes: antipsychotic medication use data report October 2019.https:\/\/www.cms.gov\/files\/document\/antipsychotic\u2010medication\u2010use\u2010data\u2010report\u2010updated\u201001242020.pdf. Accessed on June 1 2020."},{"key":"e_1_2_11_13_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpainsymman.2016.10.369"},{"key":"e_1_2_11_14_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jamda.2019.08.030"},{"key":"e_1_2_11_15_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jamda.2014.11.018"},{"key":"e_1_2_11_16_1","doi-asserted-by":"publisher","DOI":"10.1093\/gerona\/54.11.M546"},{"key":"e_1_2_11_17_1","doi-asserted-by":"publisher","DOI":"10.1097\/MLR.0000000000000334"},{"key":"e_1_2_11_18_1","doi-asserted-by":"publisher","DOI":"10.1034\/j.1601-5215.2002.51017.x"},{"key":"e_1_2_11_19_1","doi-asserted-by":"publisher","DOI":"10.1177\/1536867X1501500208"},{"key":"e_1_2_11_20_1","unstructured":"U.S. Food and Drug Administration.Public health advisory: deaths with antipsychotics in elderly patients with behavioral disturbances;2005.https:\/\/wayback.archive\u2010it.org\/7993\/20170113112252\/ http:\/\/www.fda.gov\/Drugs\/DrugSafety\/PostmarketDrugSafetyInformationforPatientsandProviders\/ucm053171.htm. Accessed on September 1 2020."},{"key":"e_1_2_11_21_1","doi-asserted-by":"publisher","DOI":"10.1186\/s12888-019-2177-5"},{"key":"e_1_2_11_22_1","doi-asserted-by":"publisher","DOI":"10.1001\/jamainternmed.2018.0379"},{"key":"e_1_2_11_23_1","doi-asserted-by":"publisher","DOI":"10.1093\/geront\/gnx083"},{"key":"e_1_2_11_24_1","doi-asserted-by":"publisher","DOI":"10.1001\/jamainternmed.2016.7491"},{"key":"e_1_2_11_25_1","article-title":"Drug therapy for delirium in terminally ill adults","volume":"1","author":"Finucane AM","year":"2020","journal-title":"Cochrane Database Syst Rev"},{"issue":"9","key":"e_1_2_11_26_1","article-title":"Olanzapine for the prevention and treatment of cancer\u2010related nausea and vomiting in adults","volume":"9","author":"Sutherland A","year":"2018","journal-title":"Cochrane Database Syst Rev"},{"key":"e_1_2_11_27_1","unstructured":"World Health Organization.Essential Medicines in Palliative Care. Executive Summary; 2013.https:\/\/www.who.int\/selection_medicines\/committees\/expert\/19\/applications\/PalliativeCare_8_A_R.pdf. Accessed January 15 2021."},{"key":"e_1_2_11_28_1","article-title":"Palliative pharmacological sedation for terminally ill adults","volume":"1","author":"Beller EM","year":"2015","journal-title":"Cochrane Database Syst Rev"},{"key":"e_1_2_11_29_1","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD006271.pub3"},{"key":"e_1_2_11_30_1","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2017.11468"},{"key":"e_1_2_11_31_1","unstructured":"Center for Medicare Chronic Care Policy Group.Medicare hospice payment reform: analysis of how the Medicare hospice benefit is used;2015.https:\/\/www.cms.gov\/Medicare\/Medicare\u2010Fee\u2010for\u2010Service\u2010Payment\/Hospice\/Downloads\/December\u20102015\u2010Technical\u2010Report.pdf. Accessed September 15 2020."},{"key":"e_1_2_11_32_1","doi-asserted-by":"publisher","DOI":"10.1111\/jgs.13795"},{"key":"e_1_2_11_33_1","doi-asserted-by":"publisher","DOI":"10.1191\/0269216302pm589oa"}],"container-title":["Journal of the American Geriatrics Society"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/jgs.17172","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full-xml\/10.1111\/jgs.17172","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/agsjournals.onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/jgs.17172","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,3]],"date-time":"2025-11-03T14:58:18Z","timestamp":1762181898000},"score":1,"resource":{"primary":{"URL":"https:\/\/agsjournals.onlinelibrary.wiley.com\/doi\/10.1111\/jgs.17172"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,4,9]]},"references-count":32,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2021,8]]}},"alternative-id":["10.1111\/jgs.17172"],"URL":"https:\/\/doi.org\/10.1111\/jgs.17172","archive":["Portico"],"relation":{},"ISSN":["0002-8614","1532-5415"],"issn-type":[{"value":"0002-8614","type":"print"},{"value":"1532-5415","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,4,9]]},"assertion":[{"value":"2020-12-11","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2021-03-22","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2021-04-09","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}